Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aethlon Medical (AEMD) Change in Cash (2016 - 2025)

Historic Change in Cash for Aethlon Medical (AEMD) over the last 15 years, with Q1 2025 value amounting to $686181.0.

  • Aethlon Medical's Change in Cash rose 12712.14% to $686181.0 in Q1 2025 from the same period last year, while for Mar 2025 it was $69590.0, marking a year-over-year increase of 10076.55%. This contributed to the annual value of $69590.0 for FY2025, which is 10076.55% up from last year.
  • Latest data reveals that Aethlon Medical reported Change in Cash of $686181.0 as of Q1 2025, which was up 12712.14% from -$2.0 million recorded in Q4 2024.
  • In the past 5 years, Aethlon Medical's Change in Cash ranged from a high of $15.3 million in Q2 2021 and a low of -$3.3 million during Q1 2022
  • In the last 5 years, Aethlon Medical's Change in Cash had a median value of -$2.2 million in 2022 and averaged -$387014.4.
  • As far as peak fluctuations go, Aethlon Medical's Change in Cash skyrocketed by 34051.58% in 2022, and later crashed by 15813.05% in 2023.
  • Over the past 5 years, Aethlon Medical's Change in Cash (Quarter) stood at -$2.8 million in 2021, then grew by 24.56% to -$2.1 million in 2022, then dropped by 4.72% to -$2.2 million in 2023, then increased by 7.72% to -$2.0 million in 2024, then soared by 133.74% to $686181.0 in 2025.
  • Its Change in Cash was $686181.0 in Q1 2025, compared to -$2.0 million in Q4 2024 and -$2.2 million in Q3 2024.